S. 527

119th Congress

Reported

Prescription Pricing for the People Act of 2025

Sponsored byRepublican:Sen. Grassley, Chuck [R-IA]IA· Introduced 11 February 2025
Open on Congress.gov

13

Cosponsors

6

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

10 April 2025·1 year ago

Summary

Introduced in Senate · Updated 1 July 2026

Prescription Pricing for the People Act of 2025

This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs.

The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs.

The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations.

Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.

Timeline

6 actions

  1. Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

    10 April 2025 · Calendars

  2. Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

    10 April 2025 · Committee

  3. Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

    10 April 2025 · Committee

  4. Committee on the Judiciary. Ordered to be reported without amendment favorably.

    3 April 2025 · Committee

  5. Read twice and referred to the Committee on the Judiciary.

    11 February 2025 · IntroReferral

  6. Introduced in Senate

    11 February 2025 · IntroReferral

Sponsorship

13 cosponsors

Sponsor

Republican:Sen. Grassley, Chuck [R-IA]IA

Cosponsors

  • Democrat646%
  • Republican754%

Classification

Policy area

Commerce

Legislative subjects

Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale tradesSupply chain

Committees

1

  • Judiciary Committee

    Senate · Standing

    • Referred To11 Feb 2025
    • Markup By3 Apr 2025
    • Reported By10 Apr 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 10 on 11 February 2025 to 13 on 9 July 2025.

Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.